Insiders Updates
Examining the Potential Price Growth of Oragenics Inc (OGEN)
Oragenics Inc’s filing revealed that its 10% Owner Odyssey Health, Inc. unloaded Company’s shares for reported $21487.0 on Jun 18
Menu
Oragenics Inc’s filing revealed that its 10% Owner Odyssey Health, Inc. unloaded Company’s shares for reported $21487.0 on Jun 18
In a filing, Oragenics Inc revealed its 10% Owner Odyssey Health, Inc. unloaded Company’s shares for reported $21487.0 on Jun
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Oragenics Inc
The biotechnology firm is developing its vaccine candidate against SARS-CoV-2. Oragenics anticipate the Phase 1 trial of TerraCoV2 beginning in